North American Biocompatibility Summit 2024

The North American Biocompatibility Summit (NABS) is a limited-seating event that provides industry insights and expertise sharing on the biocompatibility of medical devices. This year, sessions will include the latest regulatory updates, biological evaluation strategies and best practices that lead to successful biocompatibility programs in September 2024.

Led by the medical device industry’s foremost biological safety experts, speakers will address:

• Regulatory strategies and how they relate to ISO 10993
• New and innovative biocompatibility methods and technologies
• The relationship between material/chemical characterization and biocompatibility testing
• Toxicology and risk management
• Industry case studies

REGISTRATION PRICING
Early-Bird (ends August 3): $275.00
Regular: $475.00

For regular updates, please visit www.nabiocompsummit.com anytime.

NOTE: Our security measures require that your credit card billing address match your profile address.

*By registering for this event, you are providing NAMSA consent to contact you directly regarding NAMSA’s services. The information you are providing will be processed by NAMSA to better understand your product needs and interests. At any time, you can submit a request to withdraw your consent for the use of information provided by you by contacting us at: communications@namsa.com. For additional information, please visit our Privacy Policy or contact us at privacy@namsa.com.